Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 98 articles: HTML format Text format

Single Articles

September 2019
1. JAYASINGHE S, Liu B, Gidding H, Gibson A, et al
   Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort.
   Pediatr Infect Dis J. 2019;38:967-973.
   PubMed     Text format     Abstract available
   
   
   August 2019
2. LIN L, Macias Parra M, Sierra VY, Salas Cespedes A, et al
   Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
   Pediatr Infect Dis J. 2019 Aug 28. doi: 10.1097/INF.0000000000002437.
   PubMed     Text format     Abstract available
   
   
   
3. EDWARDS K, Lambert PH, Black S
   Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
   Pediatr Infect Dis J. 2019;38:873-876.
   PubMed     Text format     Abstract available
   
   
   
4. DANIER J, Rivera L, Claeys C, Dbaibo G, et al
   Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.
   Pediatr Infect Dis J. 2019;38:866-872.
   PubMed     Text format     Abstract available
   
   
   July 2019
5. MEJIAS A, Rodriguez-Fernandez R, Peeples ME, Ramilo O, et al
   Respiratory Syncytial Virus Vaccines: Are We Making Progress?
   Pediatr Infect Dis J. 2019 Jul 18. doi: 10.1097/INF.0000000000002404.
   PubMed     Text format    
   
   
   
6. EUN BW, Lee TJ, Lee J, Kim KH, et al
   A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.
   Pediatr Infect Dis J. 2019 Jul 16. doi: 10.1097/INF.0000000000002406.
   PubMed     Text format     Abstract available
   
   
   
7. CHANTHAVANICH P, Anderson E, Kerdpanich P, Bulitta M, et al
   Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects.
   Pediatr Infect Dis J. 2019;38:757-764.
   PubMed     Text format     Abstract available
   
   
   
8. YOUSAFZAI MT, Riaz A, Omer SB, Husain S, et al
   Development and Validation of Parental Vaccine Attitudes Scale for Use in Low-income Setting.
   Pediatr Infect Dis J. 2019;38:e143-e148.
   PubMed     Text format     Abstract available
   
   
   June 2019
9. RIVERO I, Raguindin PF, Buttler R, Martinon-Torres F, et al
   False Vaccine Contraindications Among Healthcare Providers in Europe: A Short Survey Among Members of The European Society of Pediatric Infectious Diseases.
   Pediatr Infect Dis J. 2019 Jun 21. doi: 10.1097/INF.0000000000002401.
   PubMed     Text format     Abstract available
   
   
   
10. HUBICHE T, Brazier C, Vabret A, Reynaud S, et al
    MEASLES TRANSMISSION IN A FULLY VACCINATED CLOSED COHORT: Data From a Nosocomial Clustered Cases in a Teenage Psychiatric Unit.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002372.
    PubMed     Text format     Abstract available
    
    
    
11. WILCOX CR, Calvert A, Metz J, Kilich E, et al
    Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002384.
    PubMed     Text format     Abstract available
    
    
    
12. NOLAN T, Booy R, Marshall HS, Richmond P, et al
    Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
    Pediatr Infect Dis J. 2019;38:643-650.
    PubMed     Text format     Abstract available
    
    
    
13. CHIU M, Bao C, Sadarangani M
    Dilemmas With Rotavirus Vaccine: The Neonate and Immunocompromised.
    Pediatr Infect Dis J. 2019;38.
    PubMed     Text format     Abstract available
    
    
    May 2019
14. HEMMING-HARLO M, Lahdeaho ML, Maki M, Vesikari T, et al
    Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents.
    Pediatr Infect Dis J. 2019;38:539-541.
    PubMed     Text format     Abstract available
    
    
    
15. CORONEL D, Garcia-Rivera EJ, Rivera M, Arredondo-Garcia JL, et al
    Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4-5 Years After a Primary 3-Dose Schedule.
    Pediatr Infect Dis J. 2019;38:e90-e95.
    PubMed     Text format     Abstract available
    
    
    April 2019
16. MAKGATHO E, Patel F, Solomon F, Groome MJ, et al
    The Burden of Acute Diarrheal Disease in Young Hospitalized Urban South African Children Five Years After Rotavirus Vaccine Introduction: A Retrospective Descriptive Study.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002304.
    PubMed     Text format     Abstract available
    
    
    
17. GIDDING HF, Sheridan S, Fathima P, Moore HC, et al
    Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002314.
    PubMed     Text format     Abstract available
    
    
    
18. SLACK M, Vyse A, Madhava H, Reinert RR, et al
    Ongoing Exposure of U.K. Infants to Vaccine Serotype Pneumococci.
    Pediatr Infect Dis J. 2019;38:444.
    PubMed     Text format    
    
    
    
19. GROSSMAN Z, Hadjipanayis A, Degani A, Somekh E, et al
    Tracking Changes in Vaccine Attitudes and Decisions: Results from 2008 and 2016 Parental Surveys.
    Pediatr Infect Dis J. 2019;38:e75-e76.
    PubMed     Text format     Abstract available
    
    
    
20. XU J, Stek JE, Ziani E, Liu GF, et al
    Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
    Pediatr Infect Dis J. 2019;38:439-443.
    PubMed     Text format     Abstract available
    
    
    
21. MOODLEY K, Coovadia YM, Cohen C, Meiring S, et al
    Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008.
    Pediatr Infect Dis J. 2019;38:424-430.
    PubMed     Text format     Abstract available
    
    
    
22. FARNAES L, Coufal NG, Spector SA
    Vaccine Strain Varicella Infection in an Infant With Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2019;38:413-415.
    PubMed     Text format     Abstract available
    
    
    March 2019
23. STEIN-ZAMIR C, Sokolov I, Abramson N, Shoob H, et al
    Pertussis Outbreak in Infants and an Immunization Campaign Based on Providing Pertussis Vaccine Doses at 6 Weeks, 10 Weeks, and 14 Weeks.
    Pediatr Infect Dis J. 2019;38:e63-e64.
    PubMed     Text format    
    
    
    February 2019
24. CURTIS N
    BCG Vaccination and All-Cause Neonatal Mortality.
    Pediatr Infect Dis J. 2019;38:195-197.
    PubMed     Text format    
    
    
    December 2018
25. PLOTKIN SA, Offit PA, Reiss D
    Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines.
    Pediatr Infect Dis J. 2018;37:e353.
    PubMed     Text format    
    
    
    
26. PALMU AA, Lahdenkari M
    Re: "First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants".
    Pediatr Infect Dis J. 2018;37:e352-e353.
    PubMed     Text format    
    
    
    
27. DAGAN R, Pelton S, Bakaletz L, Cohen R, et al
    First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants.
    Pediatr Infect Dis J. 2018;37:e351-e352.
    PubMed     Text format    
    
    
    November 2018
28. XU J, Stek JE, Ziani E, Liu GF, et al
    Integrated Safety Profile of a New Approved, Fully-liquid DTaP5-HB-IPV-Hib Vaccine.
    Pediatr Infect Dis J. 2018 Nov 27. doi: 10.1097/INF.0000000000002257.
    PubMed     Text format     Abstract available
    
    
    
29. WILCOX CR, Calvert A, Metz J, Kilich E, et al
    Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant Women and Healthcare Professionals.
    Pediatr Infect Dis J. 2018 Nov 9. doi: 10.1097/INF.0000000000002242.
    PubMed     Text format     Abstract available
    
    
    
30. SPOULOU V, Alain S, Gabutti G, Giaquinto C, et al
    Implementing Universal Varicella Vaccination in Europe: The Path Forward.
    Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002233.
    PubMed     Text format     Abstract available
    
    
    
31. MARTINON-TORRES F, Diez-Domingo J, Feroldi E, Jordanov E, et al
    Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.
    Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002231.
    PubMed     Text format     Abstract available
    
    
    
32. ROBERTSON CA, Mercer M, Selmani A, Klein NP, et al
    Safety and Immunogenicity of a Full-Dose Split-Virion Inactivated Quadrivalent Influenza Vaccine in Healthy Children 6 to 35 Months of Age: A Randomized Controlled Clinical Trial.
    Pediatr Infect Dis J. 2018 Nov 2. doi: 10.1097/INF.0000000000002227.
    PubMed     Text format     Abstract available
    
    
    
33. CORTES M, Lopez P, Marquez V, Cortes C, et al
    Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia.
    Pediatr Infect Dis J. 2018;37:1190-1191.
    PubMed     Text format     Abstract available
    
    
    October 2018
34. CLAEYS C, Chandrasekaran V, Garcia-Sicilia J, Prymula R, et al
    Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naive Children.
    Pediatr Infect Dis J. 2018 Oct 15. doi: 10.1097/INF.0000000000002217.
    PubMed     Text format     Abstract available
    
    
    
35. SIGAUQUE B, Moiane B, Massora S, Pimenta F, et al
    Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Pediatr Infect Dis J. 2018;37:1054-1060.
    PubMed     Text format     Abstract available
    
    
    
36. WALLS T, Cho V, Martin N, Williman J, et al
    Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
    Pediatr Infect Dis J. 2018;37:1041-1047.
    PubMed     Text format     Abstract available
    
    
    September 2018
37. JAYARAMAN K, Adhisivam B, Nallasivan S, Krishnan RG, et al
    Two Randomized Trials of the Effect of BCG-Russia Alone or With Oral Polio Vaccine on Neonatal Mortality in Infants Weighing <2000 G in India.
    Pediatr Infect Dis J. 2018 Sep 25. doi: 10.1097/INF.0000000000002198.
    PubMed     Text format     Abstract available
    
    
    
38. FARNAES L, Coufal N, Spector SA
    Vaccine Strain Varicella Infection in an Infant with Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002183.
    PubMed     Text format     Abstract available
    
    
    August 2018
39. OLSON D, Rick AM, Krager S, Lamb M, et al
    Vaccine Demand and Willingness-to-Pay for Arbovirus Vaccines: A Cross Sectional Survey in Rural Guatemala.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002169.
    PubMed     Text format     Abstract available
    
    
    
40. MBUTHIA JK, Kabera BM, Karuga R, Ivui G, et al
    A Cross-sectional Study to Compare Hepatitis B Immunity in HIV-infected and HIV-uninfected Kenyan Children After Primary Hepatitis B Immunization.
    Pediatr Infect Dis J. 2018;37:e214-e215.
    PubMed     Text format     Abstract available
    
    
    July 2018
41. GROSSMAN Z, Hadjipanayis A, Degani A, Somekh E, et al
    Tracking Changes in Vaccine Attitudes and Decisions: Results from 2008 and 2016 Parental Surveys.
    Pediatr Infect Dis J. 2018 Jul 11. doi: 10.1097/INF.0000000000002147.
    PubMed     Text format     Abstract available
    
    
    
42. MAKWANA A, Sheppard C, Borrow R, Fry N, et al
    Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Pediatr Infect Dis J. 2018;37:697-703.
    PubMed     Text format     Abstract available
    
    
    June 2018
43. YANG Y, Yang Y, Scherpbier RW, Zhu X, et al
    Coverage of Haemophilus influenzae Type b Conjugate Vaccine for Children in Mainland China: Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J. 2018 Jun 27. doi: 10.1097/INF.0000000000002132.
    PubMed     Text format     Abstract available
    
    
    
44. KADLECEK V, Borja-Tabora CF, Eder-Lingelbach S, Gatchalian S, et al
    Antibody Persistence up to 3 Years after Primary Immunization with Inactivated Japanese Encephalitis Vaccine IXIARO(R) in Philippine Children and Effect of a Booster Dose.
    Pediatr Infect Dis J. 2018 Jun 15. doi: 10.1097/INF.0000000000002124.
    PubMed     Text format     Abstract available
    
    
    
45. 
    Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: ERRATUM.
    Pediatr Infect Dis J. 2018;37:611.
    PubMed     Text format    
    
    
    May 2018
46. PRYMULA R, Kieninger D, Feroldi E, Jordanov E, et al
    Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000002109.
    PubMed     Text format     Abstract available
    
    
    
47. MOODLEY K, Coovadia YM, Cohen C, Meiring S, et al
    Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003 - 2008.
    Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002096.
    PubMed     Text format     Abstract available
    
    
    
48. 
    Vaccination in Pregnancy-Recent Developments: ERRATUM.
    Pediatr Infect Dis J. 2018;37:465.
    PubMed     Text format    
    
    
    
49. 
    Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy: ERRATUM.
    Pediatr Infect Dis J. 2018;37:450.
    PubMed     Text format    
    
    
    April 2018
50. NAZIAT H, Saha S, Islam M, Saha S, et al
    Epidemiology of Otitis Media with Otorrhea Among Bangladeshi Children: Baseline Study for Future Assessment of Pneumococcal Conjugate Vaccine Impact.
    Pediatr Infect Dis J. 2018 Apr 9. doi: 10.1097/INF.0000000000002077.
    PubMed     Text format     Abstract available
    
    
    March 2018
51. MERINO ARRIBAS JM, Carmona Martinez A, Horn M, Perez Porcuna XM, et al
    Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Co-Administered with MenACWY-TT in Infants: Results of an Open, Randomized Trial.
    Pediatr Infect Dis J. 2018 Mar 31. doi: 10.1097/INF.0000000000002061.
    PubMed     Text format     Abstract available
    
    
    
52. RIISE OR, Laake I, Vestrheim D, Winje BA, et al
    Preterm Children Have Higher Risk Than Full-Term Children of Invasive Pneumococcal Disease During the First Two Years of Life.
    Pediatr Infect Dis J. 2018 Mar 21. doi: 10.1097/INF.0000000000001989.
    PubMed     Text format     Abstract available
    
    
    
53. GETACHEW HB, Dahl RM, Lopman BA, Parashar UD, et al
    Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001-2015.
    Pediatr Infect Dis J. 2018 Mar 14. doi: 10.1097/INF.0000000000001988.
    PubMed     Text format     Abstract available
    
    
    
54. OH CE, Choi UY, Eun BW, Lee TJ, et al
    A Randomized, Double-Blind, Active-Controlled Clinical Trial of a Cell Culture-Derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age.
    Pediatr Infect Dis J. 2018 Mar 9. doi: 10.1097/INF.0000000000001973.
    PubMed     Text format     Abstract available
    
    
    
55. JACOBS K, Posa M, Spellicy W, Otero J, et al
    Adult Caregiver Influenza Vaccination Through Administration in Pediatric Outpatient Clinics: A Cocooning Healthcare Improvement Project.
    Pediatr Infect Dis J. 2018 Mar 2. doi: 10.1097/INF.0000000000001970.
    PubMed     Text format     Abstract available
    
    
    February 2018
56. NEUZIL KM
    Quantifying the Impact of Maternal Influenza Vaccination: Beyond Laboratory-Confirmed Efficacy.
    Pediatr Infect Dis J. 2018 Feb 24. doi: 10.1097/INF.0000000000001967.
    PubMed     Text format    
    
    
    
57. UBUKATA K, Morozumi M, Sakuma M, Takata M, et al
    Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates after Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Pediatr Infect Dis J. 2018 Feb 22. doi: 10.1097/INF.0000000000001956.
    PubMed     Text format     Abstract available
    
    
    
58. LI-KIM-MOY J, Wood N, Jones C, Macartney K, et al
    Impact of Fever and Antipyretic Use on Influenza Vaccine Immune Reponses in Children.
    Pediatr Infect Dis J. 2018 Feb 19. doi: 10.1097/INF.0000000000001949.
    PubMed     Text format     Abstract available
    
    
    
59. MASSEY J, Nair A, Dietz S, Snaman D, et al
    Hospital, Maternal, and Birth Factors Associated with Hepatitis B Vaccination at Birth - West Virginia, 2015.
    Pediatr Infect Dis J. 2018 Feb 16. doi: 10.1097/INF.0000000000001953.
    PubMed     Text format     Abstract available
    
    
    
60. KAORU H, Igarashi R, Hoshina T, Kojiro M, et al
    Utility of the Performance of Lumbar Puncture for Febrile Children with Status Epilepticus in the Bacterial Conjugate Vaccine Era.
    Pediatr Infect Dis J. 2018 Feb 15. doi: 10.1097/INF.0000000000001945.
    PubMed     Text format     Abstract available
    
    
    
61. OMER SB, Clark DR, Aqil AR, Tapia MD, et al
    Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa.
    Pediatr Infect Dis J. 2018 Feb 13. doi: 10.1097/INF.0000000000001914.
    PubMed     Text format     Abstract available
    
    
    
62. TELJEUR C, Moran PS, Harrington P, Butler K, et al
    Economic Evaluation of Selective Neonatal BCG Vaccination of High-Risk Infants in Ireland.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001891.
    PubMed     Text format     Abstract available
    
    
    
63. WITTE D, Cunliffe NA, Turner AM, Ngulube E, et al
    Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001937.
    PubMed     Text format     Abstract available
    
    
    
64. HAVERS FP, Fry AM, Peacock G, Chen J, et al
    Influenza Vaccination Coverage in Children with Neurologic Disorders and Their Siblings, July 2006-June 2014.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001929.
    PubMed     Text format     Abstract available
    
    
    
65. LIN L, Parra MM, Sierra VY, Cespedes AS, et al
    Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine in 4-6 Year-Old Girls: Results to Month 12 from a Randomized Trial.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001871.
    PubMed     Text format     Abstract available
    
    
    
66. MENG QH, Luo J, Yang F, Shen YJ, et al
    A General Lack of IgG Against Pertussis Toxin in Chinese Pregnant Women and Newborns.
    Pediatr Infect Dis J. 2018 Feb 5. doi: 10.1097/INF.0000000000001933.
    PubMed     Text format     Abstract available
    
    
    
67. DAHL RM, Curns AT, Tate JE, Parashar UD, et al
    Effect of Rotavirus Vaccination on Acute Diarrheal Hospitalizations Among Low and Very Low Birth Weight US Infants, 2001-2015.
    Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001930.
    PubMed     Text format     Abstract available
    
    
    
68. BERGERO PE, Fabricius G, Hozbor DF, Theeten H, et al
    Potential Impact of Changes in the Schedule for Primary Diphtheria-Tetanus Toxoids-Pertussis Immunization as Control Strategy for Pertussis.
    Pediatr Infect Dis J. 2018;37:e36-e42.
    PubMed     Text format     Abstract available
    
    
    
69. ROSENBLUT A, Rosenblut M, Garcia K, Maul X, et al
    Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile.
    Pediatr Infect Dis J. 2018;37:132-134.
    PubMed     Text format     Abstract available
    
    
    January 2018
70. BURKE RM, Tate JE, Pringle KD, Patel M, et al
    Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants.
    Pediatr Infect Dis J. 2018 Jan 16. doi: 10.1097/INF.0000000000001907.
    PubMed     Text format     Abstract available
    
    
    
71. SZENBORN L, Block SL, Jackowska T, Konior R, et al
    Immune Responses to Booster Vaccination with Meningococcal ABCWY Vaccine Following Primary Vaccination with Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
    Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001896.
    PubMed     Text format     Abstract available
    
    
    
72. CUNNINGHAM-ERVES JL, Kelly-Taylor KD, Mayo-Gamble TL, Deakings JA, et al
    A Physician's Recommendation for HPV Vaccination: What Makes African American Mothers Compliant?
    Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001906.
    PubMed     Text format     Abstract available
    
    
    
73. TRUCK J, Kelly S, Jawad S, Snape MD, et al
    Differences in Immunization Site Pain in Toddlers Vaccinated with Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2018 Jan 10. doi: 10.1097/INF.0000000000001894.
    PubMed     Text format     Abstract available
    
    
    
74. BLACK S
    Editor's Commentary: Vaccines as a Tool to Combat Antibiotic Resistance.
    Pediatr Infect Dis J. 2018;37:96.
    PubMed     Text format    
    
    
    
75. ALFONSO VH, Doshi RH, Mukadi P, Higgins SG, et al
    Prevalence of Rubella Antibodies Among Children in the Democratic Republic of the Congo.
    Pediatr Infect Dis J. 2018;37:28-34.
    PubMed     Text format     Abstract available
    
    
    
76. NDUBA V, Van't Hoog AH, Mitchell EMH, Borgdorff M, et al
    Incidence of Active Tuberculosis and Cohort Retention Among Adolescents in Western Kenya.
    Pediatr Infect Dis J. 2018;37:10-15.
    PubMed     Text format     Abstract available
    
    
    December 2017
77. EYTHORSSON E, Hrafnkelsson B, Erlendsdottir H, Atli Gudmundsson S, et al
    Decreased AOM with Treatment Failure Following Introduction of the Ten-Valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001870.
    PubMed     Text format     Abstract available
    
    
    
78. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
    PubMed     Text format     Abstract available
    
    
    
79. BADAHDAH AM, Khatami A, Tashani M, Rashid H, et al
    Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001861.
    PubMed     Text format     Abstract available
    
    
    
80. RYBAK A, Levy C, Bonacorsi S, Bechet S, et al
    Antibiotic Resistance of Potential Otopathogens Isolated from Nasopharyngeal Flora of Children with Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001862.
    PubMed     Text format     Abstract available
    
    
    
81. PALMU AA, Lahdenkari M
    Early Vaccine-Type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared to Early Acute Otitis Media Due to Other Bacterial Etiology.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001851.
    PubMed     Text format     Abstract available
    
    
    
82. LU CY, Tsai HC, Huang YC, Huang DT, et al
    A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.
    Pediatr Infect Dis J. 2017;36:e307-e312.
    PubMed     Text format     Abstract available
    
    
    
83. MCNAIR J, Smith A, Bettinger JA, Vaudry W, et al
    Invasive Haemophilus influenzae Type b (Hib) Infections in Children with Cancer in the Era of Infant Hib Immunization Programs (1991-2014): A Report from the Canadian Immunization Monitoring Program Active.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001850.
    PubMed     Text format     Abstract available
    
    
    November 2017
84. SANTOS VS, Nobrega FA, Soares MWS, Moreira RD, et al
    Rotavirus Genotypes Circulating in Brazil Before and After the National Rotavirus Vaccine Program: A Review.
    Pediatr Infect Dis J. 2017 Nov 17. doi: 10.1097/INF.0000000000001770.
    PubMed     Text format     Abstract available
    
    
    
85. HEININGER U
    Is There A Need For A Stand-Alone Acellular Pertussis Vaccine?
    Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001767.
    PubMed     Text format    
    
    
    
86. MOKOMANE M, Tate JE, Steenhoff AP, Esona MD, et al
    Evaluation of the Influence of Gastrointestinal Co-Infections on Rotavirus Vaccine Effectiveness in Botswana.
    Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001828.
    PubMed     Text format     Abstract available
    
    
    
87. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
    PubMed     Text format     Abstract available
    
    
    
88. JONES CE, Calvert A, Le Doare K
    Vaccination in Pregnancy - Recent Developments.
    Pediatr Infect Dis J. 2017 Nov 11. doi: 10.1097/INF.0000000000001822.
    PubMed     Text format    
    
    
    
89. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Nonvaccination in Children With Cardiac Disease.
    Pediatr Infect Dis J. 2017;36:e268-e271.
    PubMed     Text format     Abstract available
    
    
    October 2017
90. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001810.
    PubMed     Text format     Abstract available
    
    
    
91. GARRIDO-GARCIA LM, Castillo-Moguel A, Vazquez-Rivera M, Cravioto P, et al
    Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
    Pediatr Infect Dis J. 2017;36:e237-e241.
    PubMed     Text format     Abstract available
    
    
    September 2017
92. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    PubMed     Text format     Abstract available
    
    
    
93. BERNAOLA E, Gil F, Herranz M, Gil-Setas A, et al
    Pneumococcal Vaccination and Pneumonia Associated with Pleural Effusion in a Pediatric Population.
    Pediatr Infect Dis J. 2017 Sep 20. doi: 10.1097/INF.0000000000001798.
    PubMed     Text format     Abstract available
    
    
    
94. BAXTER RP, Lewis N, Fireman B, Hansen J, et al
    Live Attenuated Influenza Vaccination Prior To Age 3 Years and Subsequent Development of Asthma: A 14-Year Follow-Up Study.
    Pediatr Infect Dis J. 2017 Sep 12. doi: 10.1097/INF.0000000000001783.
    PubMed     Text format     Abstract available
    
    
    August 2017
95. DIONNE-ODOM J, Westfall AO, Nzuobontane D, Vinikoor MJ, et al
    Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.
    Pediatr Infect Dis J. 2017 Aug 2. doi: 10.1097/INF.0000000000001728.
    PubMed     Text format     Abstract available
    
    
    February 2017
96. NEWMAN LP, Njoroge A, Magaret A, Chohan BH, et al
    Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001572.
    PubMed     Text format     Abstract available
    
    
    August 2016
97. CHIAPPINI E, Berti E, Sollai S, Orlandini E, et al
    Dramatic Pertussis Resurgence in Tuscan Infants in 2014.
    Pediatr Infect Dis J. 2016;35:930-1.
    PubMed     Text format    
    
    
    May 2016
98. ISLAM S
    Pediatric Latent Tuberculosis: Should Travel and Foreign Birth Testing Criteria be Reassessed?
    Pediatr Infect Dis J. 2016.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: